OBJECTIVE. In this article we will illustrate the role of subtraction imaging for abdominal MRI applications.
CONCLUSION. Subtraction imaging has multiple applications for imaging the mediastinum, abdomen, and pelvis. Removing any preexisting signal of T1 unenhanced images causes contrast enhancement within a mass to become more conspicuous on subtracted sequences. This is helpful when evaluating a lesion with high signal on unenhanced T1-weighted sequences, where visual detection of enhancement can be difficult on conventional MRI. ubtraction imaging is a readily available technique that is routinely used in MRI of the breast and in MR angiography. There have been reports of subtraction imaging in the solid organs of the abdomen [1] [2] [3] [4] , however it may be underused in routine body MRI applications, including but not limited to hepatic, renal, and adrenal imaging. This pictorial essay illustrates scenarios in which subtraction imaging can be valuable in characterizing a lesion and confidently arriving at a diagnosis. In particular, subtraction imaging can be helpful in evaluating for the presence of a neoplasm in hemorrhagic masses, complicated cysts, and other settings in which determining the presence or absence of enhancement is critical. Qualitative detection of enhancement within such lesions is often not a straightforward task due to hemorrhagic or proteinaceous contents making them hyperdense on CT or high signal on unenhanced T1-weighted MRI pulse sequences. Subtraction imaging can make evaluation of these lesions more straightforward.
Technique
Subtraction imaging is a technique whereby an unenhanced T1-weighted sequence is digitally subtracted from the identical sequence performed after gadolinium administration. By performing this operation, any native T1 signal is removed and the remaining signal on the subtracted images is due solely to enhancement.
Specific Applications Simple Hemorrhage Versus Hemorrhagic Mass
In the setting of spontaneous hemorrhage within an intraabdominal organ, it is imperative to search for an underlying lesion responsible for the bleeding. Acute or subacute hemorrhage will be hyperdense on CT. On MRI, areas of high signal will be present on unenhanced T1-weighted sequences because of the presence of intracellular or extracellular methemoglobin. The presence of high density on CT or bright signal on unenhanced T1-weighted MRI sequences makes qualitative evaluation of enhancement difficult. However, any signal from blood products will be removed on subtraction images, making enhancement within a lesion much more conspicuous. Accordingly, a simple hematoma should appear as a signal void on subtraction images because it will not contain enhancing elements.
Within the liver, hepatocellular adenomas and carcinomas are the two neoplasms that are most likely to spontaneously bleed. Other causes of nontraumatic hepatic hemorrhage include HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome, coagulopathy, amyloidosis, and peliosis hepatis [5] . Acute flank pain secondary to spontaneous hemorrhage is a well-known presentation of renal cell carcinoma (Fig. 1) . Nontraumatic adrenal hemorrhage is relatively common. This can be due to a hemorrhagic mass such as an adrenal cortical carcinoma, pheochromocytoma, myelolipoma, or metastasis or it can be secondary to nonneoplastic causes such as anticoagulation, bleeding diathesis (Fig. 2) , sepsis, stress, S 1018.fm -3/6/07 or trauma [6] . In patients with an equivocal history of trauma, subtraction imaging can be used to characterize a complex splenic mass as either a hematoma or neoplasm (Fig. 3) .
Other clinical settings in which subtraction images may be useful to distinguish hematoma from tumor are in the postoperative period (Fig. 4) and in patients receiving anticoagulation therapy.
Complex Cysts
Complex renal cysts often show high signal on unenhanced T1-weighted sequences due to the presence of either intracystic hemorrhage or proteinaceous debris. These cysts are hyperdense on CT. Subtraction imaging has been shown to be highly sensitive for detection of enhancement within these lesions and thus for accurate classification as either benign hemorrhagic cysts or cystic renal cell carcinomas [4] ( Fig. 5 ). Subtraction imaging should be used for analysis of enhancement within this subset of cystic renal masses on MRI because the use of quantitative measurements (region of interest [ROI]) can result in false-negative results [4] . MRI is also not subject to pseudoenhancement artifact, which can limit evaluation of small intraparenchymal renal masses on CT because of a correction process that artifactually increases attenuation values [7] (Fig. 6 ).
Cirrhotic Nodules
In the cirrhotic liver, a nodule that exhibits enhancement greater than that of background liver on arterial-dominant gadolinium-enhanced images is presumed to be a hepatocellular carcinoma because this degree of enhancement is infrequently seen in dysplastic nodules and rarely seen in regenerative nodules [2] . However, regenerative and dysplastic nodules and hepatocellular carcinoma can all exhibit high signal on unenhanced T1-weighted sequences [2] . This can make qualitative analysis of the degree of enhancement within these lesions difficult. Subtraction imaging of dynamic gadolinium-enhanced sequences will remove any preexisting T1 signal and thus facilitate detection of lesion enhancement [2, 3] .
Postablation Procedures
Radiofrequency ablation and cryoablation are being used with increased frequency for treatment of malignancies in the liver, kidneys, and other organs. The goal of either procedure is complete tumor necrosis. Postprocedural cross-sectional imaging is used to analyze the lesion for the presence of recurrent or residual neoplasm. This is a critical determination in the management of these patients, and subtraction imaging is ideally suited for such a role. Subtraction can make subtle enhancement within a tumor more conspicuous and can remove high T1 signal, which is often present because of coagulation necrosis (Fig. 7) . It can also help differentiate the smooth, indistinct peritumoral enhancement seen in benign posttreatment hyperemia from the discontinuous nodular enhancement of viable tumor [4] .
Other Applications
Subtraction imaging may also be useful for imaging the gallbladder in situations in which the differential diagnosis is between tumefactive sludge versus wall thickening from neoplasm. Whereas sonography using color or power Doppler or CT performed with and without contrast material can suggest the diagnosis of neoplasm by showing the presence of either blood flow or enhancement within the area in question, MRI with subtraction imaging can aid in making a more confident diagnosis. This is especially true in cases of early carcinoma (Fig. 8) when there is no detectable extramural disease.
Finally, a potentially important future indication for subtraction was recently described by Ajaj et al. [8] , who showed the utility of subtraction imaging in increasing sensitivity and decreasing readout time of dark-lumen MR colonography in a study of 20 patients in whom the lesions were confirmed on conventional endoscopy.
Pitfalls of Subtraction Imaging
An imperative technical principle of subtraction imaging is to keep all parameters constant on the unenhanced and contrast-enhanced images. This includes TR, TE, flip angle, slice thickness, matrix, and zero interpolation factor. It is also essential that the patient's position remain unchanged within the magnet during the unenhanced and contrast-enhanced sequences. The patient should be able to maintain a breath-hold throughout the acquisition, and the breath-hold should be reproducible from sequence to sequence. Not fulfilling one or more of these criteria will result in misregistration artifact and image degradation on the subtraction series.
Imaging at end expiration may yield more consistent data sets than imaging at end inspiration [9] . Misregistration artifact can be identified by high signal intensity that outlines enhancing structures. If this occurs, subtracting individual images rather than entire data sets can be useful. The radiologist can select a single image from the unenhanced series and a single image from the gadoliniumenhanced series that corresponds to the identical anatomic level. The technologist can then subtract these selected images, which may reduce the degree of misregistration.
Conclusion
Subtraction MRI is an excellent technique for evaluating hemorrhagic masses or lesions with high signal intensity on unenhanced T1-weighted sequences, such as complicated cysts or hepatic nodules. Moreover, there are additional clinical scenarios in which it is essential to determine the presence or absence of enhancement within a mass. These include postablation therapy and evaluation for residual tumor versus postsurgical change. In these situations, the body imager should consider subtraction MRI as a useful problem-solving technique that can aid in arriving at a confident diagnosis. 
